Cerebellopontine angle metastatic melanoma mimicking schwannoma in a sexagenarian: Case report
Abstract
Keywords
Full Text:
PDFReferences
Arriaga MA, Lo WW, Brackmann DE. Metastatic melanoma to the cerebellopontine angle. Clinical and imaging characteristics. Arch Otolaryngol Head Neck Surg 1995;121(9):1052-1056.
Bafaloukos D, Gogas H. The treatment of brain metastases in melanoma patients. Cancer Treat Rev 2004;30(6):515-520.
Becco P, Gallo S, Poletto S, Frascione MPM, Crotto L, Zaccagna A, et al. Melanoma Brain Metastases in the Era of Target Therapies: An Overview. Cancers 2020;12(6).
Brackmann DE, Doherty JK. CPA melanoma: diagnosis and management. Otol Neurotol 2007;28(4):529-537.
Escott EJ. A variety of appearances of malignant melanoma in the head: a review. Radiographics 2001;21(3):625-639.
Fernandez E, Maira G, Puca A, Vignati A. Multiple intracranial metastases of malignant melanoma with long-term survival. Case report. J Neurosurg 1984;60(3):621-624.
Gerganov VM, Hore N, Herold C, Wrede K, Stan AC, Samii A, et al. Bilateral malignant melanoma metastases to the internal auditory canal/cerebellopontine angle: surgical management and preservation of function. J Neurosurg 2008;108(4):803-807.
González Cao M, Malvehy J, Martí R, Conill C, Sánchez M, Martín M, et al. Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma. Melanoma Res 2006;16(1):59-64.
Guzel A, Maciaczyk J, Dohmen-Scheufler H, Senturk S, Volk B, Ostertag CB, et al. Multiple intracranial melanoma metastases: case report and review of the literature. J Neurooncol 2009;93(3):413-420.
Hofmann M, Kiecker F, Wurm R, Schlenger L, Budach V, Sterry W, et al. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol 2006;76(1):59-64.
Kingdom TT, Lalwani AK, Pitts LH. Isolated metastatic melanoma of the cerebellopontine angle: case report. Neurosurgery 1993;33(1):142-144.
Lade-Keller J, Yuusufi S, Riber-Hansen R, Steiniche T, Stougaard M. Telomerase reverse transcriptase promoter mutations and solar elastosis in cutaneous melanoma. Melanoma Res 2018;28(5):398-409.
Mastorakos P, Xu Z, Yu J, Hess J, Qian J, Chatrath A, et al. BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study. Neurosurgery 2019;84(4):868-880.
Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B, et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 2004;27(2):145-149.
Panagiotou IE, Brountzos EN, Kelekis DA, Papathanasiou MA, Bafaloukos DI. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma 2005;52(2):150-158.
Tu AS, Wang H, Harris-McCorkle L, Saunders JR, Jr. Bilateral involvement of the cerebellopontine angles by malignant melanoma metastasis: a case report. Md Med J 1994;43(11):967-970.
van Wiltenburg R, Sevick RJ, Clark AW, Burger PC, LeBlanc FE. Choroidal melanoma metastasis as a rare cause of cerebellopontine angle lesion: 2 case reports. Can Assoc Radiol J 1998;49(3):185-189.
Yuh WT, Mayr-Yuh NA, Koci TM, Simon JH, Nelson KL, Zyroff J, et al. Metastatic lesions involving the cerebellopontine angle. AJNR American journal of neuroradiology 1993;14(1):99-106.
DOI: https://doi.org/10.7575/aiac.abcmed.v.10n.1p.33
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
2013-2023 (CC-BY) Australian International Academic Centre PTY.LTD.
Advances in Bioscience and Clinical Medicine